All are True about endometrial carcinoma in clinical stage III except
**Endometrial Carcinoma in Clinical Stage III**
**Core Concept**
Endometrial carcinoma in clinical stage III is characterized by the spread of cancer beyond the uterus, but not to distant organs. It involves invasion of the uterine serosa or adnexa, or metastases to pelvic or para-aortic lymph nodes. The clinical staging of endometrial cancer is crucial for determining the prognosis and treatment plan.
**Why the Correct Answer is Right**
Clinical stage III endometrial cancer often presents with deep myometrial invasion (≥ 50%), cervical involvement, or regional lymph node metastases. The presence of lymph node metastases is a significant factor in determining the prognosis and treatment strategy. In stage III, the cancer has spread beyond the uterus but not to distant organs, such as the lungs, liver, or bones.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not accurately describe clinical stage III endometrial cancer.
* **Option B:** This option is incorrect because it does not provide a characteristic of clinical stage III endometrial cancer.
* **Option D:** This option is incorrect because it does not accurately describe clinical stage III endometrial cancer.
**Clinical Pearl / High-Yield Fact**
Endometrial cancer is often asymptomatic in its early stages, and symptoms such as postmenopausal bleeding or pelvic pain may not appear until the cancer has advanced. A high index of suspicion and prompt evaluation are essential for early detection and treatment.
**Correct Answer:** Not Provided